百普賽斯(301080.SZ)一季度淨利潤預增23.05%-37.81%
格隆匯4月14日丨百普賽斯(301080.SZ)公佈,預計2022年第一季度實現營業收入1.11億元-1.17億元,同比增長24.09%-30.80%;歸屬於上市公司股東的淨利潤5000萬元-5600萬元,同比增長23.05%-37.81%;扣除非經常損益後的淨利潤5000萬元-5600萬元,同比增長23.32%-38.12%。
公司堅持以市場為導向,以滿足客户需求為目標,通過加強重點熱點產品研發,持續推出貼合市場需求的高質量產品,滿足持續增長的重組蛋白等生物試劑的市場需求。通過提升公司管理水平,建立健全營銷網絡,提升公司綜合競爭力,增強盈利能力。在公司全員的共同努力下,預計2022第一季度營業收入同比增長24.09%-30.80%。
公司預計2022第一季度非新冠病毒防疫相關產品收入為8900萬元-9200萬元,同比增長43.33%-48.16%。公司經過多年在生物醫藥、健康產業領域的深耕,在技術、研發、產品的生產和質量、品牌等方面形成了核心競爭力,以優質的產品和服務獲得了國內外客户的認可,使非新冠相關收入持續高速增長。
公司預計2022年第一季度新冠病毒防疫相關產品銷售收入2200萬元-2500萬元,同比下降8.62%-19.58%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.